Cvs Health Corporation · NYSE:CVS
Cvs Health — Q3 2024 Earnings Presentation
12 slides from Cvs Health's earnings presentation, Nov 6, 2024
Slide 1: Third quarter 2024 earnings conference call
Third quarter 2024 November 6, 2024 Earnings conference call J. David Joyner Thomas F. Cowhey President and Executive Vice President and Chief Executive Officer Chief Financial Officer 1 ©2024 CVS Health and/or one of its affiliates. Confidential and proprietary.
Slide 2: Cautionary statement concerning forward-looking statements
Cautionary statement concerning forward-looking statements This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS Health Corporation (“CVS Health”). By their nature,
Slide 3: Financial highlights
Financial highlights Delivered revenue growth of 6.3% and adjusted EPS of $1.09 in the third quarter of 2024. THIRD QUARTER Enterprise Highlights Financial Results 88% 6.3% revenue growth Medicare Advantage members in plans rated 4-stars or better by CMS $1.09 adjusted EPS $0.071 $837M GAAP EPS retu
Slide 4: Accelerating opportunities to drive integrated value
Accelerating opportunities to drive integrated value We are Increase in Aetna members using ~4x Oak Street clinics since close demonstrating progress towards Increase in Aetna members key measures of served by Signify (YoY change) ~2x success across the Increase in Caremark members enterprise, cover
Slide 5: Building a world of health around every consumer
OUR VISION Building a world of health around every consumer 5 ©2024 CVS Health and/or one of its affiliates. Confidential and proprietary.
Slide 6: Our Strategic Imperatives
Our Strategic Imperatives Grow Build Enable Create Empower our core business diverse national care consumers’ health seamless engagement our people and delivery and value- with care and and personalized culture based care capabilities coverage capabilities experiences across across local points all
Slide 7: Consolidated Results
Consolidated Results in billions, Business highlights except per share amounts Q3 2024 Q3 2023 Delivered exceptional Stars results, achieving our highest ever member experience score since Total Revenues $95.4 $89.8 CMS launched the Quality Bonus Stars Program in 2012, demonstrating the strength of
Slide 8: Superior assets. Superior care. Superior value.
Superior assets. Superior care. Superior value. 8 ©2024 CVS Health and/or one of its affiliates. Confidential and proprietary. ©2024 CVS Health and/or one of its affiliates. Confidential and proprietary. 8
Slide 9: Health care benefits Quarter Results
Health care benefits in billions, except MBR and membership Q3 2024 Q3 2023 Business highlights Total Revenues $33.0 $26.3 Increase of ~1.4 million medical members reflects increase in Medicare and Individual Exchange, Adjusted Operating Income (Loss) ($0.92) $1.54 partially offset by Medicaid redet
Slide 10: Health services Quarter Results
Health services in billions, except pharmacy claims Q3 2024 Q3 2023 Business highlights Total Revenues $44.1 $46.9 Health Services revenue of ~$44 billion was impacted by the previously announced loss of a Quarter Results large client and continued pharmacy client price Adjusted Operating Income $2.
Slide 11: Pharmacy & consumer wellness Quarter Results
Pharmacy & consumer wellness in billions, except prescriptions filled Q3 2024 Q3 2023 Business highlights Total Revenues $32.4 $28.9 Generated revenue of ~$32 billion, reflecting an increase of ~12% versus the prior year and over ~15%4 on a Quarter Results same store basis. Adjusted Operating Income
Slide 12: Footnotes
Footnotes Third quarter 2024 1. Third quarter GAAP diluted Earnings per Share includes approximately $1.2 billion in restructuring costs, or a $0.69 impact to Adjusted Earnings per Share, reflecting impairment charges for the approximately 270 stores the Company expects to close in 2025, costs assoc